AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
17,689 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A fast-tracked Nasdaq-100 adds a new catalyst for space stocks. Rocket Lab is poised to enter the index ahead of Spac...
A veteran market analyst argues that military drones, not consumer EVs, may drive the next leap in battery technology...
A high-ranking Google DeepMind AI executive leaves for OpenAI, triggering investor chatter about Alphabet stock and t...
A 62-year-old couple with $2.3 million in a 401(k) faces a tax-efficient choice: Roth conversions. This report breaks...
SpaceX is one of the world’s most talked-about private companies. This article breaks down scenarios that could push ...
High-priced tech names can deliver big gains if growth sticks. This article breaks down how to evaluate the momentum,...
When you want bank exposure without picking winners, two popular ETFs stand out: the broad State Street SPDR ISHARES ...
Gold has shifted from peak highs to a challenging bear phase. This guide breaks down how to spot a buying opportunity...
Old Dominion Freight Line (ODFL) faced an 11.9% drop after a Citi downgrade, despite strong fundamentals. This articl...
The Federal Reserve’s newest inflation outlook suggests a higher-for-longer rate path, but investors are cautiously u...
Tesla posted solid Q1 2026 results but CEO Elon Musk tempered enthusiasm for Optimus and the Robotaxi, signaling grad...